These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 36688301)

  • 21. Beta-Blocker Use and Heart Failure Outcomes in Mildly Reduced and Preserved Ejection Fraction.
    Arnold SV; Silverman DN; Gosch K; Nassif ME; Infeld M; Litwin S; Meyer M; Fendler TJ
    JACC Heart Fail; 2023 Aug; 11(8 Pt 1):893-900. PubMed ID: 37140513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk assessment of post-discharge mortality among recently hospitalized Medicare heart failure patients with reduced or preserved ejection fraction.
    Stampehl M; Friedman HS; Navaratnam P; Russo P; Park S; Obi EN
    Curr Med Res Opin; 2020 Feb; 36(2):179-188. PubMed ID: 31469001
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of implantable haemodynamic monitoring in heart failure across ranges of ejection fraction: a systematic review and meta-analysis.
    Curtain JP; Lee MMY; McMurray JJ; Gardner RS; Petrie MC; Jhund PS
    Heart; 2023 May; 109(11):823-831. PubMed ID: 36522146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
    Heart; 2018 Mar; 104(6):525-532. PubMed ID: 28982721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction.
    Lin TK; Hsu BC; Li YD; Chen CH; Lin JW; Chien CY; Weng CY
    J Am Heart Assoc; 2019 Jun; 8(12):e010739. PubMed ID: 31181979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preeclampsia Predicts Risk of Hospitalization for Heart Failure With Preserved Ejection Fraction.
    Williams D; Stout MJ; Rosenbloom JI; Olsen MA; Joynt Maddox KE; Deych E; Davila-Roman VG; Lindley KJ
    J Am Coll Cardiol; 2021 Dec; 78(23):2281-2290. PubMed ID: 34857089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.
    Zile MR; Kjellstrom B; Bennett T; Cho Y; Baicu CF; Aaron MF; Abraham WT; Bourge RC; Kueffer FJ
    Circ Heart Fail; 2013 May; 6(3):508-16. PubMed ID: 23515277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction.
    Liu D; Hu K; Schregelmann L; Hammel C; Lengenfelder BD; Ertl G; Frantz S; Nordbeck P
    ESC Heart Fail; 2023 Apr; 10(2):1358-1371. PubMed ID: 36732921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex differences in long-term outcomes following acute heart failure hospitalization: Findings from the Get With The Guidelines-Heart Failure registry.
    Keshvani N; Shah S; Ayodele I; Chiswell K; Alhanti B; Allen LA; Greene SJ; Yancy CW; Alonso WW; Van Spall HG; Fonarow GC; Heidenreich PA; Pandey A
    Eur J Heart Fail; 2023 Sep; 25(9):1544-1554. PubMed ID: 37632339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries.
    Fudim M; Zhong L; Patel KV; Khera R; Abdelmalek MF; Diehl AM; McGarrah RW; Molinger J; Moylan CA; Rao VN; Wegermann K; Neeland IJ; Halm EA; Das SR; Pandey A
    J Am Heart Assoc; 2021 Nov; 10(22):e021654. PubMed ID: 34755544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Abnormal Left Ventricular Functional Reserve With Outcome in Heart Failure With Preserved Ejection Fraction.
    Kosmala W; Przewlocka-Kosmala M; Rojek A; Mysiak A; Dabrowski A; Marwick TH
    JACC Cardiovasc Imaging; 2018 Dec; 11(12):1737-1746. PubMed ID: 29153571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.
    Lund LH; Claggett B; Liu J; Lam CS; Jhund PS; Rosano GM; Swedberg K; Yusuf S; Granger CB; Pfeffer MA; McMurray JJV; Solomon SD
    Eur J Heart Fail; 2018 Aug; 20(8):1230-1239. PubMed ID: 29431256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT Trial.
    Silverman DN; Plante TB; Infeld M; Callas PW; Juraschek SP; Dougherty GB; Meyer M
    JAMA Netw Open; 2019 Dec; 2(12):e1916598. PubMed ID: 31800067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.
    Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J
    JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of the International Classification of Diseases, Tenth Revision, codes of heart failure in an administrative database.
    Bosco-Lévy P; Duret S; Picard F; Dos Santos P; Puymirat E; Gilleron V; Blin P; Chatellier G; Looten V; Moore N
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):194-200. PubMed ID: 30395375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.